¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù.
À̹ø¿¡ Åä¿äÀÏ ¼¼¹Ì³ª¿¡¼ ¹ßÇ¥ µå¸± ³í¹®Àº
Áö³´Þ (2020³â 8¿ù) nature¿¡ ¹ßÇ¥µÈ ³í¹®À¸·Î
Á¦¸ñÀº "cDC1 prime and licensed by CD4+ T cells to induced anti-tumour immunity" ÀÔ´Ï´Ù.
±âÁ¸¿¡ cDC1Àº CD8+ T cell response¸¦ À¯µµÇϴµ¥ ƯȵǾî ÀÖ°í, cDC2ÀÇ °æ¿ì CD4+ T cell response¸¦ À¯µµÇϴµ¥ Æ¯È µÇ¾î ÀÖ¾î ÀÖ´Ù°í º¸°í µÇ¾úÀ¸¸ç, tumour protectionÀÇ °üÁ¡¿¡¼´Â CD4+ T cellÀÇ ¿ªÇÒÀº CD8+ T cell ÀÇ È°¼ºÀ» º¸Á¶ÇÏ´Â °ÍÀ¸·Î ¹Þ¾Æµé¿© Áö°í ÀÖ¾ú½À´Ï´Ù.
¹°·Ð cDC1ÀÌ CD4+ T cell ¹ÝÀÀÀ» ÀüÇô À¯µµÇÏÁö ¸øÇÏ´Â °ÍÀº ¾Æ´Ï¸ç, ¸î¸î in vitro½ÇÇèÀ» ±â¹ÝÀ¸·Î ÇÑ º¸°í¿¡¼ CD4+ T cell ¹ÝÀÀ¿¡¼ÀÇ ¿ªÇÒÀ» °Á¶Çϱ⵵ Çß½À´Ï´Ù. ÇÏÁö¸¸ in vivo¿¡¼ÀÇ ¿¬±¸´Â ÀÌ·ç¾î Áø °ÍÀÌ ¾ø¾ú´Âµ¥,
À̹ø ³í¹®¿¡¼ cDC1ÀÌ Á÷Á¢ÀûÀ¸·Î CD4+ T cellÀÇ ¹ÝÀÀ¿¡µµ °ü¿©¸¦ Çϸç, ±× ¹ÝÀÀÀÌ tumour-protectionÀÇ °üÁ¡¿¡¼µµ ¸Å¿ì Áß¿äÇÔÀ» ´Ù¾çÇÑ conditional KO mouse¸¦ ÀÌ¿ëÇÏ¿© in vivo ¼öÁØ¿¡¼ ¹àÇû½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
³í¹® ¸µÅ© : https://www.nature.com/articles/s41586-020-2611-3